Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Welcome to Definitive Healthcare’s Q4 2024 Earnings Call.

Q4 2024 Earnings Call Transcript February 28, 2025 Rapid Micro Biosystems, Inc. reports earnings inline with expectations.

Reiterates 2025 guidance, with the number of patients on LUMRYZ expected to increase to 3,300-3,500 by year-end, generating $240-$260 million in net product revenue and cash flow of $20-40 million -- ...

EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to its Board of Directors. “We are pleased to ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following approval of the permanent J-c ...

But the lack of balance affects how the treatment effect is interpreted: in a main-effects-only model, there are no significant differences between the treatment means themselves (Type I F-test p > ...

Detailed price information for Tactile Systems Technology Inc (TCMD-Q) from The Globe and Mail including charting and trades.